Natriuretic peptides, respiratory disease, and the right heart.

Natriuretic peptides, respiratory disease, and the right heart.

It is well-recognized that atrial natriuretic peptide (ANP) and B-type natriuretic peptide (BNP) are raised in conditions with ventricular volume and pressure overload. In addition to this established role in left ventricular congestive cardiac failure, there is good evidence that BNP has a diagnost...

Disgrifiad llawn

Manylion Llyfryddiaeth
Prif Awduron:	Yap, L, Mukerjee, D, Timms, P, Ashrafian, H, Coghlan, J
Fformat:	Journal article
Iaith:	English
Cyhoeddwyd:	2004

Eitemau Tebyg

The natriuretic peptides and their role in disorders of right heart dysfunction and pulmonary hypertension.
gan: Yap, L, et al.
Cyhoeddwyd: (2004)

B-type natriuretic peptide-guided treatment for heart failure
gan: McLellan, J, et al.
Cyhoeddwyd: (2016)

A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure.
gan: Doust, J, et al.
Cyhoeddwyd: (2004)

Plasma N-terminal pro-brain natriuretic peptide has similar predictive value to brain natriuretic peptide in diagnosis of heart failure in the community
gan: Hobbs, R, et al.
Cyhoeddwyd: (2000)

Left atrial volume is an independent predictor of serum natriuretic peptide in heart failure but normal left ventricular systolic function: implication for diagnosis of diastolic heart failure
gan: Lim, T, et al.
Cyhoeddwyd: (2005)

Essential components in natriuretic peptide-guided management of heart failure: An intervention synthesis
gan: Oke, J, et al.
Cyhoeddwyd: (2018)

Natriuretic peptide-guided treatment for heart failure: a systematic review and meta-analysis
gan: McLellan, J, et al.
Cyhoeddwyd: (2019)

Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2014)

Reciprocal effects of systemic inflammation and brain natriuretic peptide on adiponectin biosynthesis in adipose tissue of patients with ischemic heart disease.
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2014)

Natriuretic peptide testing and heart failure diagnosis in primary care: diagnostic accuracy study
gan: Taylor, CJ, et al.
Cyhoeddwyd: (2022)

B-type and N-terminal pro-B-type natriuretic peptides in heart failure
gan: Kurtinecz, M
Cyhoeddwyd: (2018)

Increased left atrial volume index is an independent predictor of raised serum natriuretic peptide in patients with suspected heart failure but normal left ventricular ejection fraction: Implication for diagnosis of diastolic heart failure.
gan: Lim, T, et al.
Cyhoeddwyd: (2006)

Plasma brain natriuretic peptide assay is valuable in diagnosis of heart failure in the community, as well as in hospital
gan: Davis, R, et al.
Cyhoeddwyd: (2000)

Prediction of heart failure by amino terminal-pro-B-type natriuretic peptide and C-reactive protein in subjects with cerebrovascular disease.
gan: Campbell, D, et al.
Cyhoeddwyd: (2005)

Natriuretic peptide level at heart failure diagnosis and risk of hospitalisation and death in England 2004-2018
gan: Taylor, C, et al.
Cyhoeddwyd: (2021)

N-terminal pro-B-type natriuretic peptide and vascular disease among 20,536 patients in the MRC/BHF heart protection study
gan: Emberson, J, et al.
Cyhoeddwyd: (2005)

Interrelation of coronary effects of atrial natriuretic peptide and the renin-angiotensin system in the isolated perfused rat heart.
gan: Bauer, W, et al.
Cyhoeddwyd: (1994)

Brain Natriuretic Peptide Overrides the Effects of Systemic Inflammation and Globally Increases Adiponectin Biosynthesis in Human Adipose Tissue of Patients With Ischaemic Heart Disease
gan: Antonopoulos, A, et al.
Cyhoeddwyd: (2013)

Long term trends in natriuretic peptide testing for heart failure in UK primary care: a cohort study
gan: Roalfe, A, et al.
Cyhoeddwyd: (2021)

Evidence against C-type natriuretic peptide as an arterial 'EDHF'.
gan: Garland, C, et al.
Cyhoeddwyd: (2008)

Respiratory disturbances in congenital heart disease
gan: Davies, H
Cyhoeddwyd: (1965)

Clinical significance of N-terminal-probrain natriuretic peptide in hypertrophic cardiomyopathy.
gan: Efthimiadis, G, et al.
Cyhoeddwyd: (2007)

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review.
gan: Doust, J, et al.
Cyhoeddwyd: (2005)

How well does B-type natriuretic peptide predict death and cardiac events in patients with heart failure: systematic review
gan: Doust, J, et al.
Cyhoeddwyd: (2005)

Opioid peptides do not modulate atrial natriuretic peptide or aldosterone release under basal conditions in man.
gan: Borges, F, et al.
Cyhoeddwyd: (1988)

THE EFFECTS OF OPIOID AGONISTS AND ANTAGONISTS ON ATRIAL-NATRIURETIC-PEPTIDE (ANP) RELEASE IN MAN
gan: Borges, F, et al.
Cyhoeddwyd: (1986)

Diagnostic triage and the role of natriuretic peptide testing and echocardiography for suspected heart failure: an appropriateness ratings evaluation by UK GPs.
gan: Campbell, S, et al.
Cyhoeddwyd: (2011)

Natriuretic peptide guided therapy for management of patients with heart failure does not show improvement compared with usual medical therapy alone
gan: McLellan, J, et al.
Cyhoeddwyd: (2018)

N-terminal Pro-B-type natriuretic peptide, vascular disease risk, and cholesterol reduction among 20,536 patients in the MRC/BHF heart protection study.
gan: Emberson, JR, et al.
Cyhoeddwyd: (2007)

C-type natriuretic peptide co-ordinates cardiac structure and function
gan: Chu, SM, et al.
Cyhoeddwyd: (2019)

A role for natriuretic peptides as well as endothelins in the hypoxic lungs of patients with chronic obstructive pulmonary disease.
gan: Dorrington, K
Cyhoeddwyd: (1999)

Clinical significance of N-terminal proBrain natriuretic peptide in hypertophic cardiomyopathy
gan: Efthimiadis, G, et al.
Cyhoeddwyd: (2006)

PLASMA-LEVELS OF ATRIAL NATRIURETIC PEPTIDE (ANP) IN OBSTRUCTIVE SLEEP-APNEA (OSA)
gan: Warley, A, et al.
Cyhoeddwyd: (1988)

Combination of drugs acting on the natriuretic system and the renin-angiotensin system in heart failure.
gan: Chee, K.H., et al.
Cyhoeddwyd: (2003)

Brain natriuretic peptide is a potentially useful screening tool for the detection of cardiovascular disease in patients with rheumatoid arthritis.
gan: Harney, S, et al.
Cyhoeddwyd: (2006)

Diagnostic accuracy of point-of-care natriuretic peptide testing for chronic heart failure in ambulatory care: a systematic review and meta-analysis
gan: Taylor, K, et al.
Cyhoeddwyd: (2018)

Effects Of Atrial Natriuretic Peptide And Pregnancy On The Central And Peripheral Regulation Of The Cardiovascular Functions
gan: Yusoff, Nurul Hasnida Mohammad
Cyhoeddwyd: (2010)

Lack of effect of an inspiratory threshold load on plasma atrial natriuretic peptide levels.
gan: Warley, A, et al.
Cyhoeddwyd: (1990)

ELEVATED LEVELS OF N-TERMINAL BRAIN NATRIURETIC PEPTIDE AND TROPONIN T CORRELATE WITH KIDNEY FUNCTION AND PREDICT OUTCOMES IN CHRONIC KIDNEY DISEASE PATIENTS
gan: Landray, M, et al.
Cyhoeddwyd: (2005)

Diagnostic accuracy and clinical impact of natriuretic peptide screening for the detection of heart failure in the community: a protocol for systematic review and meta-analysis
gan: Goyder, CR, et al.
Cyhoeddwyd: (2019)